Annual ROA
-61.27%
+14.30%+18.92%
December 31, 2023
Summary
- As of March 2, 2025, MRSN annual return on assets is -61.27%, with the most recent change of +14.30% (+18.92%) on December 31, 2023.
- During the last 3 years, MRSN annual ROA has fallen by -15.04% (-32.53%).
- MRSN annual ROA is now -167.20% below its all-time high of -22.93%, reached on December 31, 2016.
Performance
MRSN ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROA
-36.01%
+8.48%+19.06%
September 30, 2024
Summary
- As of March 2, 2025, MRSN quarterly return on assets is -36.01%, with the most recent change of +8.48% (+19.06%) on September 30, 2024.
- Over the past year, MRSN quarterly ROA has increased by +28.84% (+44.47%).
- MRSN quarterly ROA is now -176.15% below its all-time high of -13.04%, reached on December 31, 2016.
Performance
MRSN Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROA Formula
ROA = Net Income
Total Assets ✕ 100%
Total Assets ✕ 100%
MRSN ROA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +18.9% | +44.5% |
| 3 y3 years | -32.5% | +44.5% |
| 5 y5 years | +0.3% | +44.5% |
MRSN ROA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +18.9% | at high | +56.8% |
| 5 y | 5-year | -102.1% | +18.9% | -52.3% | +56.8% |
| alltime | all time | -167.2% | +46.3% | -176.2% | +56.8% |
Mersana Therapeutics ROA History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -36.01%(-19.1%) |
| Jun 2024 | - | -44.49%(-14.6%) |
| Mar 2024 | - | -52.07%(-13.2%) |
| Dec 2023 | -61.27%(-18.9%) | -60.00%(-7.5%) |
| Sep 2023 | - | -64.85%(-9.1%) |
| Jun 2023 | - | -71.32%(-2.6%) |
| Mar 2023 | - | -73.19%(-2.1%) |
| Dec 2022 | -75.57%(+6.5%) | -74.75%(-10.3%) |
| Sep 2022 | - | -83.36%(+2.1%) |
| Jun 2022 | - | -81.62%(+5.8%) |
| Mar 2022 | - | -77.15%(+8.8%) |
| Dec 2021 | -70.93%(+53.4%) | -70.94%(+21.4%) |
| Sep 2021 | - | -58.44%(+26.7%) |
| Jun 2021 | - | -46.14%(+6.2%) |
| Mar 2021 | - | -43.44%(+6.3%) |
| Dec 2020 | -46.23% | -40.86%(+0.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2020 | - | -40.75%(-9.4%) |
| Jun 2020 | - | -45.00%(-17.6%) |
| Mar 2020 | - | -54.60%(+130.9%) |
| Dec 2019 | -30.32%(-50.6%) | -23.65%(-19.8%) |
| Sep 2019 | - | -29.48%(-3.3%) |
| Jun 2019 | - | -30.49%(+11.0%) |
| Mar 2019 | - | -27.48%(-55.0%) |
| Dec 2018 | -61.43%(+87.1%) | -61.05%(+29.3%) |
| Sep 2018 | - | -47.23%(+18.3%) |
| Jun 2018 | - | -39.94%(+5.7%) |
| Mar 2018 | - | -37.79%(+9.2%) |
| Dec 2017 | -32.83%(+43.2%) | -34.62%(+57.9%) |
| Sep 2017 | - | -21.93%(-3.4%) |
| Jun 2017 | - | -22.70%(+38.4%) |
| Mar 2017 | - | -16.40%(+25.8%) |
| Dec 2016 | -22.93%(-79.9%) | -13.04% |
| Dec 2015 | -114.01% | - |
FAQ
- What is Mersana Therapeutics annual return on assets?
- What is the all time high annual ROA for Mersana Therapeutics?
- What is Mersana Therapeutics annual ROA year-on-year change?
- What is Mersana Therapeutics quarterly return on assets?
- What is the all time high quarterly ROA for Mersana Therapeutics?
- What is Mersana Therapeutics quarterly ROA year-on-year change?
What is Mersana Therapeutics annual return on assets?
The current annual ROA of MRSN is -61.27%
What is the all time high annual ROA for Mersana Therapeutics?
Mersana Therapeutics all-time high annual return on assets is -22.93%
What is Mersana Therapeutics annual ROA year-on-year change?
Over the past year, MRSN annual return on assets has changed by +14.30% (+18.92%)
What is Mersana Therapeutics quarterly return on assets?
The current quarterly ROA of MRSN is -36.01%
What is the all time high quarterly ROA for Mersana Therapeutics?
Mersana Therapeutics all-time high quarterly return on assets is -13.04%
What is Mersana Therapeutics quarterly ROA year-on-year change?
Over the past year, MRSN quarterly return on assets has changed by +28.84% (+44.47%)